FDA Slaps Black Box Warning On Plavix

By Pete Brush

Law360, New York (March 15, 2010, 4:32 PM ET) -- The U.S. Food and Drug Administration has added a black box warning to the packaging of Plavix, saying between 2 and 14 percent of the U.S. population cannot properly metabolize the blood-thinning drug and do not benefit from its use.

The heightened warning, announced Friday, comes more than a year after the agency said it was working with the drug's makers, Sanofi-Aventis SA and Bristol-Myers Squibb Co., to examine the impact of genetic factors on its efficacy.

The companies said Friday that approximately 2 percent of...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles